4/A
Changes in Ownership
Zymeworks Inc. Filed Acc 0000899243-22-039331
Chief Medical Officer sold 2,475 shares at $8.10 ($20,045)
- Chief Medical Officer acquired 5,885 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Josephson Neil Chief Medical Officer | 2022-11-10 | Option exercise | +5,885 | 16,924 | D | ||
| Josephson Neil Chief Medical Officer | 2022-11-10 | Sale | −2,475 | $8.10 | $20,045 | 14,449 | D |
| Derivatives | |||||||
| Josephson Neil Chief Medical Officer | 2022-11-10 | Option exercise · Restricted Stock Unit | −5,885 | 11,772 | D | ||
| Open-market sales · 2,475 sh · avg $8.10 · $20,045 | |||||||
Loading xslF345X03/doc4a.xml…